CD8A and neoplasm: cDC1 plays an important role in eliciting an anti-tumor CD8+ T cell response mediated by MHC-I and supports T cell effector functions by releasing IL-12, while cDC2 appears to be involved in the activation of CD4+ T cells mediated by MHC-II [127].